CD44 and non-small cell lung carcinoma: Serglycin, another CD44 ligand, facilitates tumorigenesis through its glycosaminoglycans-mediated binding, regulating CD44 expression via β-catenin signaling and promoting migration in non-small cell lung cancer [54,55].